Singapore Patent Expands Island's ISLA 101 Viral Protection
Filed with ASX · · 2 pages · English
Island Pharmaceuticals Ltd on 6ix
Story so far
Earlier from Island Pharmaceuticals
- FDA Grants Orphan Designation for Galidesivir in Marburg
- Investor Presentation - Asia Dengue Summit
- Investor presentation
- Island Secures USAMRIID Support for Galidesivir Study
- Island Advances Galidesivir GMP Manufacturing for Biodefence
Later from Island Pharmaceuticals
- Pause in Trading
- Galidesivir approved for treatment use in in Ebola epidemic
- Investor Presentation - Ebola Clinical Program
- Texas Biomed SOW accelerates pivotal FDA pathway
- Quarterly Appendix 4C and Activities Report
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals